MX9301192A - Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped. - Google Patents

Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.

Info

Publication number
MX9301192A
MX9301192A MX9301192A MX9301192A MX9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A
Authority
MX
Mexico
Prior art keywords
interleukin
disease
guest
versus
suppress graft
Prior art date
Application number
MX9301192A
Other languages
English (en)
Spanish (es)
Inventor
Maria-Grazia Roncarolo
Rene De Waal Malefyt
Rosa Bacchetta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9301192A publication Critical patent/MX9301192A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX9301192A 1992-03-04 1993-03-03 Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped. MX9301192A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84620892A 1992-03-04 1992-03-04

Publications (1)

Publication Number Publication Date
MX9301192A true MX9301192A (es) 1994-08-31

Family

ID=25297256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301192A MX9301192A (es) 1992-03-04 1993-03-03 Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.

Country Status (11)

Country Link
EP (1) EP0629130A1 (ko)
JP (1) JPH07504437A (ko)
KR (1) KR950700079A (ko)
CN (1) CN1079166A (ko)
AU (1) AU679908B2 (ko)
CA (1) CA2131524A1 (ko)
IL (1) IL104916A0 (ko)
MX (1) MX9301192A (ko)
NZ (1) NZ249754A (ko)
WO (1) WO1993017698A1 (ko)
ZA (1) ZA931489B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510719A (ja) * 1993-02-01 1996-11-12 ユニヴェルシテ リブル ドゥ ブリュッセル アンスティテュション ダンセニュマン ユニヴェルシテル 有効量のインターロイキン−１０、その類似体および／または作動薬を含有する医薬組成物の使用
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
CZ1497A3 (en) * 1994-07-05 1997-05-14 Steeno Res Group As Polypeptide, its use and pharmaceutical composition based thereon, a nucleotide sequence and antibody
AU5344996A (en) * 1995-03-23 1996-10-08 Governors Of Dalhousie College And University A process of prolonging organ allograft survival
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
JPH11510806A (ja) * 1995-08-09 1999-09-21 シェーリング コーポレイション 免疫抑制治療のためのインターロイキン１０およびシクロスポリンの併用
AU4385696A (en) 1996-01-18 1997-08-11 Christian Gronhoj Larsen Synthetic il-10 analogues
US6090413A (en) * 1996-03-25 2000-07-18 Lee; Timothy D. Process of prolonging organ allograft survival
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy
AU5195098A (en) * 1996-11-06 1998-05-29 Schering Corporation Renaturation and purification of viral interleukin-10 (vil-10)
US6358506B1 (en) 1997-11-05 2002-03-19 University Of Southern California Use of cytokines and mitogens to inhibit pathological immune responses
WO1999030730A1 (en) * 1997-12-15 1999-06-24 Universite Laval Methods and compositions for improving the success of cell transplantation in a host
US6803036B1 (en) 1998-03-03 2004-10-12 University Of Southern California Use of cytokines, cells and mitogens to inhibit graft versus host disease
US6447765B1 (en) 1998-03-03 2002-09-10 University Of Southern California Use of cytokines and mitogens to inhibit graft versus host disease
JP5008810B2 (ja) 2000-04-11 2012-08-22 ユニバーシティ オブ サザン カリフォルニア 抑制性Ｔ細胞を誘導するためにＴＧＦ−βを用いる移植拒絶反応を防止する方法
CN105106214A (zh) * 2015-08-05 2015-12-02 范国煌 抑制移植物抗宿主病的新型Lck的小分子抑制剂
SG10201606949QA (en) 2016-08-19 2018-03-28 Singapore Health Serv Pte Ltd Immunosuppressive composition for use in treating immunological disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
KR950700079A (ko) 1995-01-16
IL104916A0 (en) 1993-07-08
AU679908B2 (en) 1997-07-17
CA2131524A1 (en) 1993-09-16
EP0629130A1 (en) 1994-12-21
ZA931489B (en) 1993-10-28
WO1993017698A1 (en) 1993-09-16
NZ249754A (en) 1997-06-24
CN1079166A (zh) 1993-12-08
AU3732893A (en) 1993-10-05
JPH07504437A (ja) 1995-05-18

Similar Documents

Publication Publication Date Title
MX9301192A (es) Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
EA199900168A1 (ru) Применение glp-1 или его аналогов в лечении инфаркта миокарда
IT9067127A0 (it) Anello di sutura per protesi valvolari cardiache
AU544561B2 (en) Cycling-pressure sleeve for patients limb
NO308126B1 (no) Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel
ES2029905T3 (es) Implantacion para fijar protesis dental.
MX9101224A (es) 1-alfa hidroxi vitamina d4 novedosa e intermediarios y analogos novedosos
ES1017741Y (es) Acoplamiento para protesis de extremidades.
SE8404707D0 (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
FI933193A0 (fi) Behandling av neoplastisk sjukdom med interleukin-10
SE8802869L (sv) Kombination av pyrimidinderivat och retinoider som separata komponenter foer att inducera och stimulera haartillvaext och minska dess avfall
MX7636E (es) Un metodo para la preparacion de una vacuna para la proteccion de aves de corral contra la bronquitis infecciosa
RU95103436A (ru) Способ замедления прогрессирования атеросклероза коронарных артерий с помощью правастатина
IT1217365B (it) Griglia di guida assiale per compressori
DE3772051D1 (de) Prothese zur expansion des hautgewebes.
ES2166834T3 (es) Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.
MX9206135A (es) Metodos
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
FI870890A (fi) Antiglaucomafoereningar.
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
MY100443A (en) Topical preparation for treating herpes simplex virus infection
SE8306384D0 (sv) Farmaceutisk komposition
LV5070A3 (lv) Panemiens notekudenu biologiskai attirisanai
MX7582E (es) Procedimiento para la preparacion de una vacuna contra la babesiosis de bovino